Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 21 | 2022 | 154 | 9.720 |
Why?
|
| Cochlear Implantation | 18 | 2022 | 99 | 4.690 |
Why?
|
| Cochlear Implants | 23 | 2022 | 110 | 4.480 |
Why?
|
| Hearing Loss, Sensorineural | 11 | 2021 | 110 | 3.480 |
Why?
|
| Skull Base | 8 | 2018 | 72 | 3.410 |
Why?
|
| Speech Perception | 18 | 2022 | 261 | 3.010 |
Why?
|
| Meniere Disease | 4 | 2022 | 31 | 2.620 |
Why?
|
| Eustachian Tube | 7 | 2022 | 31 | 2.110 |
Why?
|
| Ear Diseases | 6 | 2022 | 37 | 2.060 |
Why?
|
| Temporal Bone | 7 | 2019 | 53 | 2.060 |
Why?
|
| Retrospective Studies | 39 | 2022 | 7277 | 1.780 |
Why?
|
| Mastoidectomy | 4 | 2022 | 7 | 1.740 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 4 | 2016 | 15 | 1.660 |
Why?
|
| Child, Preschool | 19 | 2021 | 3187 | 1.640 |
Why?
|
| Osteomyelitis | 3 | 2017 | 40 | 1.630 |
Why?
|
| Internship and Residency | 4 | 2022 | 596 | 1.550 |
Why?
|
| Dilatation | 4 | 2022 | 58 | 1.540 |
Why?
|
| Hearing Tests | 12 | 2021 | 70 | 1.470 |
Why?
|
| Ear, Inner | 4 | 2022 | 47 | 1.470 |
Why?
|
| Otolaryngology | 3 | 2020 | 38 | 1.430 |
Why?
|
| Humans | 92 | 2022 | 68618 | 1.420 |
Why?
|
| Child | 22 | 2022 | 6405 | 1.410 |
Why?
|
| Obesity | 6 | 2018 | 1076 | 1.390 |
Why?
|
| Deafness | 7 | 2022 | 64 | 1.300 |
Why?
|
| Prevalence | 12 | 2021 | 1619 | 1.300 |
Why?
|
| Otologic Surgical Procedures | 4 | 2021 | 23 | 1.210 |
Why?
|
| Carotid Artery, Internal | 2 | 2019 | 85 | 1.200 |
Why?
|
| Clinical Competence | 3 | 2022 | 657 | 1.160 |
Why?
|
| Male | 53 | 2021 | 37321 | 1.150 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2017 | 35 | 1.150 |
Why?
|
| Tinnitus | 7 | 2021 | 22 | 1.150 |
Why?
|
| Audiometry | 5 | 2020 | 50 | 1.110 |
Why?
|
| Treatment Outcome | 28 | 2022 | 7029 | 1.070 |
Why?
|
| Female | 49 | 2021 | 38074 | 1.070 |
Why?
|
| Neurosurgical Procedures | 3 | 2015 | 98 | 1.020 |
Why?
|
| Semicircular Canals | 3 | 2020 | 9 | 1.010 |
Why?
|
| Infant | 13 | 2021 | 2891 | 1.010 |
Why?
|
| Aged | 31 | 2021 | 14862 | 0.950 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 9 | 0.930 |
Why?
|
| Cerebrospinal Fluid Leak | 4 | 2018 | 32 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2019 | 2324 | 0.880 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 4848 | 0.860 |
Why?
|
| Video Recording | 2 | 2020 | 145 | 0.850 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 12 | 0.840 |
Why?
|
| Endolymphatic Hydrops | 1 | 2022 | 4 | 0.820 |
Why?
|
| Databases, Factual | 7 | 2020 | 622 | 0.760 |
Why?
|
| Middle Aged | 34 | 2021 | 21147 | 0.750 |
Why?
|
| Neuroma, Acoustic | 4 | 2019 | 17 | 0.750 |
Why?
|
| Postoperative Complications | 7 | 2018 | 1615 | 0.740 |
Why?
|
| Hypocalcemia | 1 | 2020 | 13 | 0.730 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2020 | 6 | 0.730 |
Why?
|
| Vestibular Diseases | 1 | 2020 | 11 | 0.720 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2020 | 10 | 0.720 |
Why?
|
| Reoperation | 4 | 2018 | 467 | 0.710 |
Why?
|
| Mastoid | 3 | 2022 | 20 | 0.710 |
Why?
|
| Adult | 33 | 2022 | 21403 | 0.710 |
Why?
|
| Marfan Syndrome | 1 | 2020 | 42 | 0.710 |
Why?
|
| Audiometry, Pure-Tone | 7 | 2022 | 96 | 0.710 |
Why?
|
| Vertigo | 5 | 2020 | 24 | 0.690 |
Why?
|
| Turner Syndrome | 1 | 2019 | 10 | 0.690 |
Why?
|
| Labyrinth Diseases | 1 | 2019 | 3 | 0.690 |
Why?
|
| Cochlear Diseases | 1 | 2019 | 2 | 0.690 |
Why?
|
| Hearing Loss, Unilateral | 2 | 2020 | 7 | 0.690 |
Why?
|
| Malnutrition | 1 | 2020 | 28 | 0.680 |
Why?
|
| Migraine Disorders | 1 | 2020 | 66 | 0.680 |
Why?
|
| Otitis Externa | 2 | 2018 | 14 | 0.670 |
Why?
|
| Pregnancy in Diabetics | 1 | 2020 | 70 | 0.670 |
Why?
|
| Sickle Cell Trait | 1 | 2019 | 24 | 0.660 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 694 | 0.640 |
Why?
|
| Kartagener Syndrome | 1 | 2017 | 3 | 0.610 |
Why?
|
| Cerebral Palsy | 1 | 2018 | 24 | 0.610 |
Why?
|
| Propionibacterium acnes | 1 | 2017 | 10 | 0.600 |
Why?
|
| Dwarfism, Pituitary | 1 | 2017 | 4 | 0.590 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.590 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.590 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 318 | 0.590 |
Why?
|
| Anus, Imperforate | 1 | 2017 | 3 | 0.580 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 176 | 0.570 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 33 | 0.570 |
Why?
|
| Ectodermal Dysplasia | 1 | 2017 | 8 | 0.570 |
Why?
|
| Growth Disorders | 1 | 2017 | 21 | 0.570 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.570 |
Why?
|
| Propionibacterium | 1 | 2016 | 1 | 0.570 |
Why?
|
| Young Adult | 15 | 2021 | 5717 | 0.570 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 13 | 0.570 |
Why?
|
| Hearing Aids | 3 | 2022 | 34 | 0.570 |
Why?
|
| Hypothyroidism | 1 | 2017 | 24 | 0.560 |
Why?
|
| Duane Retraction Syndrome | 1 | 2016 | 5 | 0.560 |
Why?
|
| Quality Improvement | 3 | 2021 | 413 | 0.560 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2017 | 62 | 0.560 |
Why?
|
| Pancreatic Diseases | 1 | 2017 | 66 | 0.560 |
Why?
|
| Otitis Media | 3 | 2022 | 35 | 0.560 |
Why?
|
| Health Status Disparities | 1 | 2020 | 326 | 0.560 |
Why?
|
| Hearing | 4 | 2021 | 133 | 0.550 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2016 | 13 | 0.550 |
Why?
|
| Down Syndrome | 1 | 2017 | 120 | 0.540 |
Why?
|
| Adolescent | 12 | 2021 | 8912 | 0.540 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 378 | 0.540 |
Why?
|
| Aneurysm, False | 1 | 2016 | 60 | 0.540 |
Why?
|
| Cystic Fibrosis | 2 | 2017 | 283 | 0.530 |
Why?
|
| Intellectual Disability | 1 | 2017 | 114 | 0.520 |
Why?
|
| Aspergillosis | 1 | 2015 | 20 | 0.520 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 47 | 0.510 |
Why?
|
| Round Window, Ear | 1 | 2015 | 8 | 0.500 |
Why?
|
| Ear | 1 | 2015 | 12 | 0.500 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 1851 | 0.500 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 95 | 0.500 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 83 | 0.490 |
Why?
|
| Hearing Loss, Sudden | 1 | 2014 | 4 | 0.490 |
Why?
|
| Endolymphatic Sac | 1 | 2014 | 6 | 0.480 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.480 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 55 | 0.470 |
Why?
|
| Disease Progression | 4 | 2019 | 1038 | 0.460 |
Why?
|
| Hearing Loss, Bilateral | 4 | 2022 | 13 | 0.460 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 156 | 0.460 |
Why?
|
| Diabetes Complications | 1 | 2015 | 249 | 0.460 |
Why?
|
| Length of Stay | 2 | 2018 | 780 | 0.430 |
Why?
|
| Depression | 1 | 2020 | 943 | 0.430 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 186 | 0.430 |
Why?
|
| Prospective Studies | 9 | 2022 | 3705 | 0.430 |
Why?
|
| Hallermann's Syndrome | 1 | 2012 | 1 | 0.430 |
Why?
|
| Risk Factors | 7 | 2020 | 5731 | 0.420 |
Why?
|
| United States | 8 | 2020 | 7367 | 0.420 |
Why?
|
| Ear Canal | 1 | 2012 | 24 | 0.420 |
Why?
|
| Facial Nerve | 2 | 2017 | 25 | 0.420 |
Why?
|
| Ear Neoplasms | 1 | 2012 | 13 | 0.420 |
Why?
|
| Plasmacytoma | 1 | 2012 | 15 | 0.420 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 23 | 0.410 |
Why?
|
| Skull | 1 | 2012 | 63 | 0.410 |
Why?
|
| Comorbidity | 3 | 2020 | 1426 | 0.390 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1553 | 0.370 |
Why?
|
| Algorithms | 3 | 2016 | 1196 | 0.360 |
Why?
|
| Cochlea | 4 | 2022 | 169 | 0.350 |
Why?
|
| Auditory Threshold | 3 | 2022 | 206 | 0.340 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 114 | 0.300 |
Why?
|
| Sinusitis | 3 | 2022 | 432 | 0.300 |
Why?
|
| Speech Reception Threshold Test | 2 | 2019 | 25 | 0.290 |
Why?
|
| Chronic Disease | 4 | 2022 | 1330 | 0.290 |
Why?
|
| Age Factors | 4 | 2020 | 1864 | 0.280 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1140 | 0.270 |
Why?
|
| Acoustic Impedance Tests | 3 | 2021 | 11 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.260 |
Why?
|
| Otosclerosis | 1 | 2004 | 2 | 0.250 |
Why?
|
| Stapes Surgery | 1 | 2004 | 3 | 0.250 |
Why?
|
| Ear, Middle | 3 | 2021 | 32 | 0.240 |
Why?
|
| Quality of Life | 4 | 2022 | 1515 | 0.240 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 165 | 0.240 |
Why?
|
| Patient Satisfaction | 4 | 2021 | 378 | 0.230 |
Why?
|
| Registries | 2 | 2018 | 733 | 0.220 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 3259 | 0.220 |
Why?
|
| Cholesteatoma | 1 | 2022 | 4 | 0.210 |
Why?
|
| Noise | 3 | 2021 | 153 | 0.210 |
Why?
|
| Congenital Hypothyroidism | 1 | 2022 | 6 | 0.200 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 33 | 0.190 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2020 | 6 | 0.180 |
Why?
|
| Otoscopy | 1 | 2020 | 3 | 0.180 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 16 | 0.180 |
Why?
|
| Risk Assessment | 4 | 2018 | 2007 | 0.180 |
Why?
|
| Middle Ear Ventilation | 1 | 2020 | 7 | 0.180 |
Why?
|
| Phonetics | 2 | 2011 | 42 | 0.180 |
Why?
|
| Dizziness | 1 | 2020 | 27 | 0.180 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2021 | 46 | 0.180 |
Why?
|
| Fundoplication | 1 | 2020 | 27 | 0.180 |
Why?
|
| Vestibule, Labyrinth | 1 | 2020 | 19 | 0.180 |
Why?
|
| Hyperbilirubinemia | 1 | 2020 | 12 | 0.180 |
Why?
|
| Asphyxia Neonatorum | 1 | 2020 | 14 | 0.180 |
Why?
|
| Esophagitis | 1 | 2020 | 45 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 40 | 0.180 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 68 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 1026 | 0.170 |
Why?
|
| Models, Neurological | 2 | 2011 | 136 | 0.170 |
Why?
|
| Space Flight | 1 | 2020 | 40 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2020 | 110 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 142 | 0.170 |
Why?
|
| Speech | 3 | 2016 | 118 | 0.160 |
Why?
|
| Hospitals, Low-Volume | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 18 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 2223 | 0.150 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2800 | 0.150 |
Why?
|
| Neurotology | 1 | 2018 | 7 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2077 | 0.150 |
Why?
|
| Hearing Disorders | 1 | 2017 | 23 | 0.150 |
Why?
|
| Audiology | 1 | 2017 | 8 | 0.150 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 20 | 0.150 |
Why?
|
| Operative Time | 1 | 2017 | 45 | 0.140 |
Why?
|
| Infant, Newborn | 2 | 2020 | 2455 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 42 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 191 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 955 | 0.140 |
Why?
|
| Ossicular Prosthesis | 1 | 2016 | 10 | 0.140 |
Why?
|
| Speech Intelligibility | 1 | 2016 | 14 | 0.140 |
Why?
|
| Publishing | 1 | 2018 | 89 | 0.140 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 53 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2017 | 737 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 130 | 0.140 |
Why?
|
| Cranial Fossa, Anterior | 1 | 2016 | 8 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.130 |
Why?
|
| Angiography | 1 | 2016 | 194 | 0.130 |
Why?
|
| South Carolina | 2 | 2020 | 2752 | 0.130 |
Why?
|
| Facial Nerve Diseases | 1 | 2015 | 13 | 0.130 |
Why?
|
| Debridement | 1 | 2015 | 55 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 333 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 596 | 0.120 |
Why?
|
| Speech Discrimination Tests | 1 | 2014 | 17 | 0.120 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 25 | 0.120 |
Why?
|
| Prednisolone | 1 | 2014 | 23 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2017 | 267 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2016 | 867 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 92 | 0.120 |
Why?
|
| Administration, Topical | 1 | 2014 | 111 | 0.120 |
Why?
|
| Prednisone | 1 | 2014 | 104 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1046 | 0.120 |
Why?
|
| Pregnancy | 1 | 2020 | 2334 | 0.120 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2022 | 49 | 0.120 |
Why?
|
| Salvage Therapy | 1 | 2014 | 82 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 2014 | 99 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2014 | 150 | 0.110 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.110 |
Why?
|
| Phenotype | 1 | 2016 | 947 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 948 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 561 | 0.110 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 15 | 0.100 |
Why?
|
| Postoperative Period | 3 | 2021 | 238 | 0.100 |
Why?
|
| Tympanoplasty | 2 | 2022 | 13 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2015 | 2358 | 0.100 |
Why?
|
| Chemoradiotherapy | 1 | 2012 | 54 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 880 | 0.100 |
Why?
|
| Incidence | 1 | 2015 | 1603 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2010 | 1040 | 0.090 |
Why?
|
| Pressure | 2 | 2021 | 252 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 931 | 0.090 |
Why?
|
| Hospitalization | 1 | 2015 | 978 | 0.090 |
Why?
|
| Time Perception | 1 | 2008 | 9 | 0.080 |
Why?
|
| Barotrauma | 1 | 2007 | 3 | 0.080 |
Why?
|
| Pneumocephalus | 1 | 2007 | 12 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 53 | 0.070 |
Why?
|
| Rhinitis | 1 | 2010 | 383 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 223 | 0.060 |
Why?
|
| Foreign-Body Migration | 1 | 2004 | 38 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 521 | 0.060 |
Why?
|
| Encephalocele | 2 | 2017 | 30 | 0.060 |
Why?
|
| Geriatric Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 43 | 0.060 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2022 | 19 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2004 | 506 | 0.050 |
Why?
|
| Psychoacoustics | 2 | 2011 | 33 | 0.050 |
Why?
|
| Hyperemia | 1 | 2020 | 14 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 4655 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2003 | 384 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2019 | 10 | 0.040 |
Why?
|
| Tympanic Membrane | 1 | 2019 | 25 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 67 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 2093 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 109 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 117 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 328 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 214 | 0.040 |
Why?
|
| Inventions | 1 | 2018 | 7 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 153 | 0.040 |
Why?
|
| Endoscopy | 1 | 2022 | 464 | 0.040 |
Why?
|
| Morbidity | 1 | 2018 | 130 | 0.040 |
Why?
|
| Device Removal | 1 | 2018 | 100 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 301 | 0.040 |
Why?
|
| Speech Production Measurement | 1 | 2017 | 14 | 0.040 |
Why?
|
| Focus Groups | 1 | 2017 | 247 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 384 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 129 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2015 | 157 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2015 | 403 | 0.030 |
Why?
|
| Pediatrics | 1 | 2015 | 341 | 0.030 |
Why?
|
| Cranial Fossa, Middle | 1 | 2010 | 8 | 0.020 |
Why?
|
| Empty Sella Syndrome | 1 | 2010 | 10 | 0.020 |
Why?
|
| Meningocele | 1 | 2010 | 12 | 0.020 |
Why?
|
| Information Theory | 1 | 2010 | 1 | 0.020 |
Why?
|
| Mathematical Concepts | 1 | 2010 | 5 | 0.020 |
Why?
|
| Psycholinguistics | 1 | 2010 | 10 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 206 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Time | 1 | 2008 | 57 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 786 | 0.020 |
Why?
|
| Cues | 1 | 2011 | 654 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 706 | 0.020 |
Why?
|